Literature DB >> 25498981

NMDA receptor subunit mutations in neurodevelopmental disorders.

Nail Burnashev1, Pierre Szepetowski2.   

Abstract

N-Methyl-D-aspartate receptors (NMDARs) are glutamate-gated cation channels that are expressed throughout the brain and play essential role in brain functioning. Diversity of the subunits and of their spatio-temporal expression imparts distinct functional properties for the particular NMDAR in a particular brain region and developmental stage. Mutations in NMDARs may have pathological consequences and actually lead to various neurological disorders. Recent human genetic studies as highlighted here show the existence of multiple alterations in NMDARs subunits genes in several usual and common brain diseases, such as intellectual disability, autism spectrum disorders (ASD), or epilepsy. Relation of a particular mutation to the corresponding alteration of NMDARs function may provide an avenue to the targeted therapy for the pharmacological treatment of the disorders.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25498981     DOI: 10.1016/j.coph.2014.11.008

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  75 in total

Review 1.  Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases.

Authors:  Hongjie Yuan; Chian-Ming Low; Olivia A Moody; Andrew Jenkins; Stephen F Traynelis
Journal:  Mol Pharmacol       Date:  2015-04-22       Impact factor: 4.436

2.  De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases.

Authors:  Jia Li; Jin Zhang; Weiting Tang; Ruth K Mizu; Hirofumi Kusumoto; Wenshu XiangWei; Yuchen Xu; Wenjuan Chen; Johansen B Amin; Chun Hu; Varun Kannan; Stephanie R Keller; William R Wilcox; Johannes R Lemke; Scott J Myers; Sharon A Swanger; Lonnie P Wollmuth; Slavé Petrovski; Stephen F Traynelis; Hongjie Yuan
Journal:  Hum Mutat       Date:  2019-09-10       Impact factor: 4.878

3.  GRIN2A: involvement in movement disorders and intellectual disability without seizures.

Authors:  Antonio Gennaro Nicotera; Francesco Calì; Mirella Vinci; Sebastiano Antonino Musumeci
Journal:  Neurol Sci       Date:  2019-05-16       Impact factor: 3.307

4.  Positive allosteric modulators that target NMDA receptors rectify loss-of-function GRIN variants associated with neurological and neuropsychiatric disorders.

Authors:  Weiting Tang; Ding Liu; Stephen F Traynelis; Hongjie Yuan
Journal:  Neuropharmacology       Date:  2020-07-24       Impact factor: 5.250

5.  Probing the Structural Dynamics of the NMDA Receptor Activation by Coarse-Grained Modeling.

Authors:  Wenjun Zheng; Han Wen; Gary J Iacobucci; Gabriela K Popescu
Journal:  Biophys J       Date:  2017-06-20       Impact factor: 4.033

6.  Molecular lock regulates binding of glycine to a primitive NMDA receptor.

Authors:  Alvin Yu; Robert Alberstein; Alecia Thomas; Austin Zimmet; Richard Grey; Mark L Mayer; Albert Y Lau
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-17       Impact factor: 11.205

7.  Computer Simulations Predict High Structural Heterogeneity of Functional State of NMDA Receptors.

Authors:  Anton V Sinitskiy; Vijay S Pande
Journal:  Biophys J       Date:  2018-06-28       Impact factor: 4.033

8.  Inhibition of GluN2A NMDA receptors ameliorates synaptic plasticity deficits in the Fmr1-/y mouse model.

Authors:  Camilla J Lundbye; Anna Karina H Toft; Tue G Banke
Journal:  J Physiol       Date:  2018-09-19       Impact factor: 5.182

9.  De Novo Mutations and Rare Variants Occurring in NMDA Receptors.

Authors:  Wenshu XiangWei; Yuwu Jiang; Hongjie Yuan
Journal:  Curr Opin Physiol       Date:  2017-12-27

10.  Intelligence, Functioning, and Related Factors in Children with Cerebral Palsy.

Authors:  Gözde Türkoğlu; Serhat Türkoğlu; Canan Çelik; Halil Uçan
Journal:  Noro Psikiyatr Ars       Date:  2017-03-01       Impact factor: 1.339

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.